Skip to main content

What the FDA labels say about taking them together

Cyclosporine and ethinyl estradiol/segesterone

Ethinyl estradiol/segesterone's FDA label of April 23, 2025 names cyclosporine in its drug interactions section; the cyclosporine labels PlainMeds reads (4) do not name ethinyl estradiol/segesterone. The ethinyl estradiol/segesterone label: “Concomitant use with ethinyl estradiol-containing CHCs may increase systemic exposure of other drugs.”

Check it at the source: the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation); the ethinyl estradiol/segesterone FDA label on DailyMed (effective April 23, 2025).

What does the cyclosporine label say about ethinyl estradiol/segesterone?

Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name ethinyl estradiol/segesterone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed

What does the ethinyl estradiol/segesterone label say about cyclosporine?

Ethinyl estradiol/segesterone label, drug interactions

Concomitant use with ethinyl estradiol-containing CHCs may increase systemic exposure of other drugs (eg, cyclosporine, prednisolone, theophylline, tizanidine, and voriconazole).

Source: FDA drug label (Annovera), Mayne Pharma, effective April 23, 2025 (SPL set eb18194f-2021-41fa-8bdf-31e0c0eb646b), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Cyclosporine generic labelers
0Ethinyl estradiol/segesterone generic labelers
CyclosporineEthinyl estradiol/segesterone
Labeled forOrgan transplant rejection, Rheumatoid arthritisBirth control
Boxed warningYesYes
Pharmacy cost (NADAC)$1.04 per unit 0.05% eye emulsion$2,315.29 per ring Annovera vaginal ring
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?